SKYEPHARMA- TECHNOLOGIES - Huge Potential 2005:

This taken from Yahoo ! Message Board SKYE stateside (USA)

by: smallpharm
Long-Term Sentiment:

STRONG BUY

I've been following drug delivery companies for almost ten years.
This is really a BUYING OPPORTUNITY.There are questions about Paxil now,
but if you've been reading the annual report,you can see that the drug
pipeline (both for pharma partner and SKYE-internal products) is growing
and progressing annually.This is a very unusual company,akin to Alza
before they were aquired.They've got key technologies which can be applied
to a range of drugs,and they are just that,in a very consistent and
successful manner.Just look at how their products (or reformulated products)
move through the clinical pipeline year-to-year.There is really no reason for this stock not to hit 40 dollars per share in the next few years........
current price 6.84 USD.

But in the interim, SKYE certainly has potential to go back into the
10-12 USD range.So either way,it is a BUYING OPPORTUNITY !

Mike

.........................................................................

I concur FWIW.

Ironically,the recent plunge in sp could well be the catalyst for
a full appreciation of the TRUE worth of SKYEPHARMA !
Financial Director buying 100,000 shares at .35p, very much from the
poop-deck as it were,a very positive sign.This man is in the know
and not in the habit of throwing HIS MONEY to the wind,and evidently
loking for a quick return!

Bright times ahead...............SIT TIGHT !!!